The female mice (homozygous for Hba tm1(HBA)Tow and heterozygous for Hbb tm2(HBG1,HBB*)Tow and Hbb tm3(HBG1,HBB)Tow [h/h:: A / S ], sickle-cell trait mice) and male mice (homozygous for both Hba tm1(HBA)Tow and Hbb tm2(HBG1,HBB*)Tow [h/h:: S / S ], sickle SCD mice) were bred to generate SCD mice
Commentary: the FDA Acetaminophen Advisory Committee meeting
Plasma paraoxonase, health, inflammatory conditions, and liver function in transition dairy cows
NCOA4 inhibitors have been explored as potential therapeutic agents to prevent excessive ferritin degradation, thereby reducing intracellular free iron levels and minimizing the risk of ferroptosis (78,79)
PMID 28400207)Tier 1 primary [3]FDA approval letter for Egrifta (tesamorelin, NDA 022505, 2010)Tier 1 primary [4]Stanley TL et al